Some House Democrats expressed concerns about party leaders' plan to authorize the Government Accountability Office to set drug prices and allow HHS to negotiate prices for certain expensive drugs. Rep. Pramila Jayapal, D-Wash., said details of the plan raise many questions and concerns about whether there would be a significant effect on drug prices.
Democrats are divided over leadership plan to cut drug prices
Sign up for PCMA SmartBrief
Top news for PBMs
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.